We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$463M
AUM Growth
+$48.8M
Cap. Flow
+$67.4M
Cap. Flow %
14.57%
Top 10 Hldgs %
9.27%
Holding
349
New
97
Increased
39
Reduced
45
Closed
81

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$4.67M
2
CHTR icon
Charter Communications
CHTR
+$3.95M
3
G icon
Genpact
G
+$3.93M
4
PCRX icon
Pacira BioSciences
PCRX
+$3.26M
5
ALKS icon
Alkermes
ALKS
+$2.94M

Sector Composition

Rank Sector Weight
1 Healthcare 22.45%
2 Technology 18.35%
3 Consumer Discretionary 17.18%
4 Consumer Staples 10.71%
5 Financials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMDX icon
26
Transmedics
TMDX
$2.46B
$3.13M 0.68%
31,500
+16,800
+114% +$2.19M
HCSG icon
27
Healthcare Services Group
HCSG
$1.62B
$3.12M 0.67%
168,000
+63,000
+60% +$1.24M
QSR icon
28
Restaurant Brands International
QSR
$25.4B
$3.1M 0.67%
+42,000
New +$2.95M
ADM icon
29
Archer Daniels Midland
ADM
$42.1B
$3.05M 0.66%
42,000
+21,000
+100% +$1.42M
FSLY icon
30
Fastly Inc
FSLY
$3.2B
$3.05M 0.66%
+105,000
New +$1.72M
ALLE icon
31
Allegion
ALLE
$12B
$3.05M 0.66%
21,000
+6,300
+43% +$1M
CRUS icon
32
Cirrus Logic
CRUS
$7.04B
$3.04M 0.66%
21,000
+10,500
+100% +$1.41M
BIP icon
33
Brookfield Infrastructure Partners
BIP
$18.5B
$3.03M 0.66%
+84,000
New +$3.08M
MEDP icon
34
Medpace
MEDP
$15.1B
$3.03M 0.65%
+6,300
New +$3.23M
CVS icon
35
CVS Health
CVS
$138B
$3.02M 0.65%
42,000
CHKP icon
36
Check Point Software Technologies
CHKP
$13.3B
$3M 0.65%
21,000
PRLB icon
37
Protolabs
PRLB
$1.9B
$2.99M 0.65%
+52,500
New +$3.05M
INCY icon
38
Incyte
INCY
$23.1B
$2.96M 0.64%
31,500
+6,300
+25% +$629K
SBH icon
39
Sally Beauty Holdings
SBH
$1.4B
$2.91M 0.63%
210,000
+126,000
+150% +$1.92M
FLNC icon
40
Fluence Energy
FLNC
$1.95B
$2.89M 0.62%
+210,000
New +$4.21M
FIVE icon
41
Five Below
FIVE
$11.3B
$2.88M 0.62%
12,600
-2,100
-14% -$439K
VC icon
42
Visteon
VC
$2.75B
$2.87M 0.62%
+31,500
New +$2.98M
SHOO icon
43
Steven Madden
SHOO
$3.18B
$2.85M 0.62%
+84,000
New +$3.25M
EPAM icon
44
EPAM Systems
EPAM
$4.52B
$2.84M 0.61%
+21,000
New +$3.59M
LYFT icon
45
Lyft
LYFT
$5.57B
$2.79M 0.6%
210,000
+115,500
+122% +$1.79M
TR icon
46
Tootsie Roll Industries
TR
$2.96B
$2.77M 0.6%
64,890
-21,630
-25% -$847K
NBIX icon
47
Neurocrine Biosciences
NBIX
$17.4B
$2.77M 0.6%
21,000
SHLS icon
48
Shoals Technologies Group
SHLS
$1.75B
$2.76M 0.6%
420,000
+168,000
+67% +$1.38M
STOK icon
49
Stoke Therapeutics
STOK
$1.8B
$2.74M 0.59%
84,000
+21,000
+33% +$689K
DLO icon
50
dLocal
DLO
$4.2B
$2.72M 0.59%
210,000

Similar funds

Hussman Strategic Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Hussman Strategic Advisors held 349 positions worth $463M, up 12% from $414M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Hussman Strategic Advisors deployed $67.4M of net new capital in Q1 2026, opening 97 new positions and adding to 39 existing holdings. Its largest new stake was American Eagle Outfitters: 210,000 shares worth $3.51M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Ubiquiti, an estimated $2.85M trimmed.

  • Hussman Strategic Advisors's largest Q1 2026 buy was American Eagle Outfitters: 210,000 shares worth $3.51M.
  • Hussman Strategic Advisors added most to Corcept Therapeutics in Q1 2026, an estimated $3.53M increase.
  • Hussman Strategic Advisors's biggest Q1 2026 reduction was Ubiquiti, cutting an estimated $2.85M.
  • Hussman Strategic Advisors fully exited Qualcomm in Q1 2026, selling an estimated $4.67M.
  • Hussman Strategic Advisors's ten largest holdings make up 9.3% of its $463M portfolio in Q1 2026.
  • Hussman Strategic Advisors opened 97 new positions and closed 81 in Q1 2026.
  • Hussman Strategic Advisors's portfolio value rose 12% quarter-over-quarter to $463M.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.